Special Drug Use Surveillance for Entresto Tablets (Chronic Heart Failure, CLCZ696B1401)
Special Drug Use Surveillance for Entresto Tablets (Chronic Heart Failure, CLCZ696B1401)
This is a single arm, multicenter, observational study in Japanese chronic heart failure patients.
This study is a special drug use surveillance to evaluate the safety and efficacy of Entresto Tablets (hereafter called Entresto) clinically administered in Japanese patients for the newly approved indication of "chronic heart failure" and to be conducted as one of the RMP-specified additional pharmacovigilance activities.
Inclusion Criteria:
Exclusion Criteria:
Kasuya-gun, Fukuoka 811-2311, Japan
Mukou-City, Kyoto 617-0002, Japan
Kita-Katsuragi-gun, Nara 636-0002, Japan
Kishima-gun, Saga-ken 849-0401, Japan
Higashiohmi, Shiga 527-0134, Japan
Sunto-gun, Shizuoka 411-0917, Japan
Minato-ku, Tokyo 108-8329, Japan